News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Failed Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Alzheimer's Drug Was Hitting Target


9/11/2012 7:55:22 AM

Data from two large studies of Pfizer Inc and Johnson & Johnson's Alzheimer's drug, bapineuzumab, show the treatment reduced underlying markers of the disease in some patients, suggesting the failed medication might work at an earlier stage. The findings, presented at a European neurology meeting in Stockholm, followed the companies' announcement last month that they were scrapping large-scale clinical trials of the drug after it failed to improve memory or thinking skills in patients with mild to moderate Alzheimer's.

Read at Reuters
Read at Bloomberg
Read at CBS News
Read at Washington Post


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES